These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8211162)

  • 1. Converting tissue plasminogen activator to a zymogen: a regulatory triad of Asp-His-Ser.
    Madison EL; Kobe A; Gething MJ; Sambrook JF; Goldsmith EJ
    Science; 1993 Oct; 262(5132):419-21. PubMed ID: 8211162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants of tissue-type plasminogen activator with substantially enhanced response and selectivity toward fibrin co-factors.
    Strandberg L; Madison EL
    J Biol Chem; 1995 Oct; 270(40):23444-9. PubMed ID: 7559505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants of tissue-type plasminogen activator which display substantially enhanced stimulation by fibrin.
    Tachias K; Madison EL
    J Biol Chem; 1995 Aug; 270(31):18319-22. PubMed ID: 7629153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An active zymogen: unravelling the mystery of tissue-type plasminogen activator.
    Stubbs MT; Renatus M; Bode W
    Biol Chem; 1998 Feb; 379(2):95-103. PubMed ID: 9524060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting tissue-type plasminogen activator into a zymogen.
    Tachias K; Madison EL
    J Biol Chem; 1996 Nov; 271(46):28749-52. PubMed ID: 8910515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
    Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
    EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting tissue type plasminogen activator into a zymogen. Important role of Lys156.
    Tachias K; Madison EL
    J Biol Chem; 1997 Jan; 272(1):28-31. PubMed ID: 8995220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
    Kaslik G; Westler WM; Gráf L; Markley JL
    Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protonation state of a single histidine residue contributes significantly to the kinetics of the reaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator.
    Komissarov AA; Declerck PJ; Shore JD
    J Biol Chem; 2004 May; 279(22):23007-13. PubMed ID: 15033993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The single-chain form of tissue-type plasminogen activator has catalytic activity: studies with a mutant enzyme that lacks the cleavage site.
    Boose JA; Kuismanen E; Gerard R; Sambrook J; Gething MJ
    Biochemistry; 1989 Jan; 28(2):635-43. PubMed ID: 2496749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hemophilus influenzae Hap autotransporter is a chymotrypsin clan serine protease and undergoes autoproteolysis via an intermolecular mechanism.
    Fink DL; Cope LD; Hansen EJ; Geme JW
    J Biol Chem; 2001 Oct; 276(42):39492-500. PubMed ID: 11504735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct contributions of residue 192 to the specificity of coagulation and fibrinolytic serine proteases.
    Zhang YL; Hervio L; Strandberg L; Madison EL
    J Biol Chem; 1999 Mar; 274(11):7153-6. PubMed ID: 10066774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal and propeptide processing of human tissue plasminogen activator: activity of a pro-tPA derivative.
    Berg DT; Grinnell BW
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1289-96. PubMed ID: 1930175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the proenzyme domain of plasminogen.
    Peisach E; Wang J; de los Santos T; Reich E; Ringe D
    Biochemistry; 1999 Aug; 38(34):11180-8. PubMed ID: 10460175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low-barrier hydrogen bond in the catalytic triad of serine proteases.
    Frey PA; Whitt SA; Tobin JB
    Science; 1994 Jun; 264(5167):1927-30. PubMed ID: 7661899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide-linked propeptides stabilize the structure of zymogen and mature pancreatic serine proteases.
    Kardos J; Bódi A; Závodszky P; Venekei I; Gráf L
    Biochemistry; 1999 Sep; 38(38):12248-57. PubMed ID: 10493792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
    Rezaie AR
    Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
    Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
    J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF; Bassel-Duby RS
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3530-3. PubMed ID: 2110366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.